Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting
KRAS is commonly mutated at codon 12 in several cancer types, offering a unique opportunity for the development of neoantigen-targeted immunotherapy. Here the authors present a pipeline for the prediction, identification and validation of HLA class-I restricted mutant KRAS G12 peptides, leading to t...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5c32458bd77b40989a4cd89c57021223 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:5c32458bd77b40989a4cd89c57021223 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:5c32458bd77b40989a4cd89c570212232021-12-02T18:36:59ZBiochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting10.1038/s41467-021-24562-22041-1723https://doaj.org/article/5c32458bd77b40989a4cd89c570212232021-07-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-24562-2https://doaj.org/toc/2041-1723KRAS is commonly mutated at codon 12 in several cancer types, offering a unique opportunity for the development of neoantigen-targeted immunotherapy. Here the authors present a pipeline for the prediction, identification and validation of HLA class-I restricted mutant KRAS G12 peptides, leading to the generation of mutant KRAS-specific T cell receptors for adoptive T cell immunotherapy.Adham S. BearTatiana BlanchardJoseph CesareMichael J. FordLee P. RichmanChong XuMiren L. BarojaSarah McCuaigChristina CosteasKhatuna GabuniaJohn SchollerAvery D. PoseyMark H. O’HaraAnze SmoleDaniel J. PowellBenjamin A. GarciaRobert H. VonderheideGerald P. LinetteBeatriz M. CarrenoNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-16 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Adham S. Bear Tatiana Blanchard Joseph Cesare Michael J. Ford Lee P. Richman Chong Xu Miren L. Baroja Sarah McCuaig Christina Costeas Khatuna Gabunia John Scholler Avery D. Posey Mark H. O’Hara Anze Smole Daniel J. Powell Benjamin A. Garcia Robert H. Vonderheide Gerald P. Linette Beatriz M. Carreno Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting |
description |
KRAS is commonly mutated at codon 12 in several cancer types, offering a unique opportunity for the development of neoantigen-targeted immunotherapy. Here the authors present a pipeline for the prediction, identification and validation of HLA class-I restricted mutant KRAS G12 peptides, leading to the generation of mutant KRAS-specific T cell receptors for adoptive T cell immunotherapy. |
format |
article |
author |
Adham S. Bear Tatiana Blanchard Joseph Cesare Michael J. Ford Lee P. Richman Chong Xu Miren L. Baroja Sarah McCuaig Christina Costeas Khatuna Gabunia John Scholler Avery D. Posey Mark H. O’Hara Anze Smole Daniel J. Powell Benjamin A. Garcia Robert H. Vonderheide Gerald P. Linette Beatriz M. Carreno |
author_facet |
Adham S. Bear Tatiana Blanchard Joseph Cesare Michael J. Ford Lee P. Richman Chong Xu Miren L. Baroja Sarah McCuaig Christina Costeas Khatuna Gabunia John Scholler Avery D. Posey Mark H. O’Hara Anze Smole Daniel J. Powell Benjamin A. Garcia Robert H. Vonderheide Gerald P. Linette Beatriz M. Carreno |
author_sort |
Adham S. Bear |
title |
Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting |
title_short |
Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting |
title_full |
Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting |
title_fullStr |
Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting |
title_full_unstemmed |
Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting |
title_sort |
biochemical and functional characterization of mutant kras epitopes validates this oncoprotein for immunological targeting |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/5c32458bd77b40989a4cd89c57021223 |
work_keys_str_mv |
AT adhamsbear biochemicalandfunctionalcharacterizationofmutantkrasepitopesvalidatesthisoncoproteinforimmunologicaltargeting AT tatianablanchard biochemicalandfunctionalcharacterizationofmutantkrasepitopesvalidatesthisoncoproteinforimmunologicaltargeting AT josephcesare biochemicalandfunctionalcharacterizationofmutantkrasepitopesvalidatesthisoncoproteinforimmunologicaltargeting AT michaeljford biochemicalandfunctionalcharacterizationofmutantkrasepitopesvalidatesthisoncoproteinforimmunologicaltargeting AT leeprichman biochemicalandfunctionalcharacterizationofmutantkrasepitopesvalidatesthisoncoproteinforimmunologicaltargeting AT chongxu biochemicalandfunctionalcharacterizationofmutantkrasepitopesvalidatesthisoncoproteinforimmunologicaltargeting AT mirenlbaroja biochemicalandfunctionalcharacterizationofmutantkrasepitopesvalidatesthisoncoproteinforimmunologicaltargeting AT sarahmccuaig biochemicalandfunctionalcharacterizationofmutantkrasepitopesvalidatesthisoncoproteinforimmunologicaltargeting AT christinacosteas biochemicalandfunctionalcharacterizationofmutantkrasepitopesvalidatesthisoncoproteinforimmunologicaltargeting AT khatunagabunia biochemicalandfunctionalcharacterizationofmutantkrasepitopesvalidatesthisoncoproteinforimmunologicaltargeting AT johnscholler biochemicalandfunctionalcharacterizationofmutantkrasepitopesvalidatesthisoncoproteinforimmunologicaltargeting AT averydposey biochemicalandfunctionalcharacterizationofmutantkrasepitopesvalidatesthisoncoproteinforimmunologicaltargeting AT markhohara biochemicalandfunctionalcharacterizationofmutantkrasepitopesvalidatesthisoncoproteinforimmunologicaltargeting AT anzesmole biochemicalandfunctionalcharacterizationofmutantkrasepitopesvalidatesthisoncoproteinforimmunologicaltargeting AT danieljpowell biochemicalandfunctionalcharacterizationofmutantkrasepitopesvalidatesthisoncoproteinforimmunologicaltargeting AT benjaminagarcia biochemicalandfunctionalcharacterizationofmutantkrasepitopesvalidatesthisoncoproteinforimmunologicaltargeting AT roberthvonderheide biochemicalandfunctionalcharacterizationofmutantkrasepitopesvalidatesthisoncoproteinforimmunologicaltargeting AT geraldplinette biochemicalandfunctionalcharacterizationofmutantkrasepitopesvalidatesthisoncoproteinforimmunologicaltargeting AT beatrizmcarreno biochemicalandfunctionalcharacterizationofmutantkrasepitopesvalidatesthisoncoproteinforimmunologicaltargeting |
_version_ |
1718377861959647232 |